<DOC>
	<DOCNO>NCT01186146</DOCNO>
	<brief_summary>This randomized-controlled trial evaluate difference composite cardiac death , myocardial infarction , Stroke dual antiplatelet therapy group aspirin monotherapy group 1-year drug-eluting stent implantation .</brief_summary>
	<brief_title>Duration Clopidogrel Therapy After Drug-Eluting Stent ( DES-LATE )</brief_title>
	<detailed_description>This subsequent clinical trial previously publish pooled analysis REAL-LATE ZEST-LATE Trial , nonsignificant high trend increase rate death ( all-cause cardiac ) , myocardial infarction , stroke dual antiplatelet therapy group compare aspirin monotherapy group note .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>1 . Patients undergone DES implantation least 12 month enrollment , MACE ( death , MI , stroke , repeat revascularization ) major bleeding , dualtherapy time enrollment . 2 . Time index PCI randomization : 1218 month Contraindications use antiplatelet drug ( e.g. , concurrent bleed diathesis history major bleeding ) Concomitant vascular disease require longterm use clopidogrel Other establish indication clopidogrel therapy ( e.g. , recent ACS ) . Noncardiac coexist condition life expectancy &lt; 1 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>coronary disease</keyword>
	<keyword>stent</keyword>
	<keyword>antiplatelet drug</keyword>
	<keyword>drug-eluting stent</keyword>
</DOC>